Abstract
Background: Caffeine is the most commonly consumed pharmacologically active compound in the world. In the neonatal intensive care units (NICU), it is one of the most commonly prescribed drugs to treat Apnea of prematurity. Caffeine, the most commonly used medication in Neonatal Intensive Care Units, has calciuric and osteoclastogenic effects. Our st Aims And Objectives: udy aims to determine the association between duration of therapy of caffeine and metabolic bone disease in less than 34 weeks of gestation . All preterm babies(< 34 weeks) Inclusion Criteria: Exclusion Criteria: Methods: Neonates with major congenital anomalies and congenital bone diseases, babies >34 weeks. To determine the association between the duration of therapy of caffeine and metabolic bone disease, a prospective observational study was conducted including premature neonates less than 34 weeks . Metabolic Bone Disease was evaluated by using Biochemical parameters like calcium ,phosphorous ,ALP, calcium : creatinine ratio at 4 weeks of postnatal period . The Results: prospective observational study included 35 infants. 5.7 % had metabolic bone disease. caffeine therapy showed a association with metabolic bone disease. The duration of therapy of caffeine Conclusion: associated with metabolic bone disease and lesser the gestational age ,requirement of caffeine for longer duration in this group of study and . Future studies are needed to conrm these ndings and determine the lowest dose of caffeine needed to treat effectively apnea of prematurity
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.